The DOI matches its Crossref record.
Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban 1997
Abstract
For many years a united international classification for chronic childhood arthritis has been absent. The lack of consensus has led to difficulties in trial structure and data interpretation. The authors put forward the new ILAR classification in which the term JIA replaces JRA and JCA. The classification is based on clinical characteristics during the first 6 months of disease and divided into seven distinct categories. The ILAR classification aspires to define categories of arthritis that are clinically homogenous such that to a degree this may predict response to therapy and outcome. A detailed account of the new classification and possible pitfalls is given.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H., Deyo, R. A., Gabriel, S., Hirsch, R., Hochberg, M. C., Hunder, G. G., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23176 · Cited by 5,499
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
Helmick, C. G., Felson, D. T., Lawrence, R. C., Gabriel, S., Hirsch, R., Kwoh, C. K., Liang, M. H., Kremers, H. M., Mayes, M. D., Merkel, P. A., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23177 · Cited by 2,058
Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
Ruperto, N., Brunner, H. I., Quartier, P., Constantin, T., Wulffraat, N., Horneff, G., Brik, R., McCann, L., Kasapcopur, O., Rutkowska-Sak, L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205099 · Cited by 713
Ruperto, N., Lovell, D. J., Quartier, P., Paz, E., Rubio-Pérez, N., Silva, C. A., Abud-Mendoza, C., Burgos-Vargas, R., Gerloni, V., Melo-Gomes, J. A., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60998-8 · Cited by 560
Prevalence and incidence of juvenile idiopathic arthritis: A systematic review
Thierry, S., Fautrel, B., Lemelle, I., & Guillemin, F. (2014) · Joint Bone Spine · doi:10.1016/j.jbspin.2013.09.003 · Cited by 555
Crawley, E., Kay, R., Sillibourne, J., Patel, P., Hutchinson, I., & Woo, P. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6<1101::aid-anr6>3.0.co;2-y · Cited by 530
Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders
Sawhney, S. (2001) · Archives of Disease in Childhood · doi:10.1136/adc.85.5.421 · Cited by 467
Juvenile Idiopathic Arthritis: Will Etanercept be an Improvement over Current Therapies?
De Benedetti, F., & Ravelli, A. (2000) · BioDrugs · doi:10.2165/00063030-200014020-00003 · Cited by 428
Ravelli, A., Magni-Manzoni, S., Pistorio, A., Besana, C., Foti, T., Ruperto, N., Viola, S., & Martini, A. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.12.016 · Cited by 415
de Kleer, I. M., Wedderburn, L. R., Taams, L. S., Patel, A., Varsani, H., Klein, M., de Jager, W., Pugayung, G., Giannoni, F., Rijkers, G., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6435 · Cited by 400
Long‐term outcome in patients with juvenile idiopathic arthritis
Minden, K., Niewerth, M., Listing, J., Biedermann, T., Bollow, M., Schöntube, & Zink, A. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10444 · Cited by 379
Ruperto, N., Murray, K. J., Gerloni, V., Wulffraat, N., Feitosa De Oliveira, S. K., Falcini, F., Dolezalova, P., Alessio, M., Burgos‐Vargas, R., Corona, F., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20288 · Cited by 375
Yokota, S., Miyamae, T., Imagawa, T., Iwata, N., Katakura, S., Mori, M., Woo, P., Nishimoto, N., Yoshizaki, K., & Kishimoto, T. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20944 · Cited by 370
Quartier, P., Taupin, P., Bourdeaut, F., Lemelle, I., Pillet, P., Bost, M., Sibilia, J., Koné‐Paut, I., Gandon‐Laloum, S., LeBideau, M., et al. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10885 · Cited by 364
Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia
Ruprecht, C. R., Gattorno, M., Ferlito, F., Gregorio, A., Martini, A., Lanzavecchia, A., & Sallusto, F. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050085 · Cited by 361
Cao, D., Vollenhoven, R. V., Klareskog, L., Trollmo, C., & Malmström, V. (2004) · Arthritis Res Ther · doi:10.1186/ar1192 · Cited by 359
de Jager, W., Hoppenreijs, E. P. A. H., Wulffraat, N. M., Wedderburn, L. R., Kuis, W., & Prakken, B. J. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.061853 · Cited by 347
Bleesing, J., Prada, A., Siegel, D. M., Villanueva, J., Olson, J., Ilowite, N. T., Brunner, H. I., Griffin, T., Graham, T. B., Sherry, D. D., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22416 · Cited by 321
The German etanercept registry for treatment of juvenile idiopathic arthritis
Horneff, G., Schmeling, H., Biedermann, T., Foeldvari, I., Ganser, G., Girschick, H. J., Hospach, T., Huppertz, H. I., Keitzer, R., Küster, R. M., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.014886 · Cited by 318
Hinks, A., Barton, A., John, S., Bruce, I., Hawkins, C., Griffiths, C. E. M., Donn, R., Thomson, W., Silman, A., & Worthington, J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21049 · Cited by 306
Outcome in adults with juvenile idiopathic arthritis: A quality of life study
Foster, H. E., Marshall, N., Myers, A., Dunkley, P., & Griffiths, I. D. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10863 · Cited by 301
Woo, P., Southwood, T. R., Prieur, A.-M., Doré, C. J., Grainger, J., David, J., Ryder, C., Hasson, N., Hall, A., & Lemelle, I. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200008)43:8<1849::aid-anr22>3.0.co;2-f · Cited by 298
Martini, A., Lovell, D. J., Albani, S., Brunner, H. I., Hyrich, K. L., Thompson, S. D., & Ruperto, N. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00332-8 · Cited by 289
Saurenmann, R. K., Levin, A. V., Feldman, B. M., Rose, J. B., Laxer, R. M., Schneider, R., & Silverman, E. D. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22381 · Cited by 288
Chronic non-bacterial osteomyelitis in children
Girschick, H. J., Raab, P., Surbaum, S., Trusen, A., Kirschner, S., Schneider, P., Papadopoulos, T., Müller-Hermelink, H. K., & Lipsky, P. E. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.023838 · Cited by 286
Rheumatoid arthritis: A review of the cutaneous manifestations
Sayah, A., & English, J. C. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.07.023 · Cited by 270
Fall, N., Barnes, M., Thornton, S., Luyrink, L., Olson, J., Ilowite, N. T., Gottlieb, B. S., Griffin, T., Sherry, D. D., Thompson, S., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22981 · Cited by 245
Self-citationKaufman, K. M., Linghu, B., Szustakowski, J. D., Husami, A., Yang, F., Zhang, K., Filipovich, A. H., Fall, N., Harley, J. B., Nirmala, N. R., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38793 · Cited by 207
Inhibition of IL-6 for the treatment of inflammatory diseases
NISHIMOTO, N. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.03.005 · Cited by 200
Palermo, T. M., & Kiska, R. (2005) · The Journal of Pain · doi:10.1016/j.jpain.2004.12.005 · Cited by 173
Wong, S. C., Dobie, R., Altowati, M. A., Werther, G. A., Farquharson, C., & Ahmed, S. F. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1026 · Cited by 163
PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation
Petrelli, A., Mijnheer, G., van Konijnenburg, D. P. H., van der Wal, M. M., Giovannone, B., Mocholi, E., Vazirpanah, N., Broen, J. C., Hijnen, D., Oldenburg, B., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96107 · Cited by 126
Metadata
- Venue
- Classic Papers in Rheumatology
- Publisher
- CRC Press
- Published
- 2001-12-06
- Volume
- 25
- Issue
- 10
- Pages
- 124-125
- OpenAlex
- W107023457
- Cited by
- 1,178
- References
- 0
- FWCI
- 129.29
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.